Skip to content

Penbutolol

beta-Adrenergic Blocker — CARDIOVASCULAR SYSTEM

Also known as: betapressin, levopenbutolol, penbutolol sulfate

OfmFDA approvedATC C07AA23ATC C07CA23

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Penbutolol is an ofm drug in the beta-Adrenergic Blocker class catalogued in DrugCentral. It was first approved by the FDA in 1987. Its mechanism of action is classified as Adrenergic beta-Antagonists. DrugCentral lists 5 molecular targets, including ADRB2, ADRB1 and Htr1a. Recorded indications include Hypertensive disorder.

  • Approval status: ofm (first approved 1987 by the FDA).
  • Drug class: beta-Adrenergic Blocker.
  • Mechanism of action: Adrenergic beta-Antagonists.
  • Molecular targets: ADRB2, ADRB1, Htr1a and HTR1A (5 listed in DrugCentral).
  • Indications: Hypertensive disorder.
  • ATC code: C07AA23 (Beta blocking agents, non-selective).
  • Molecular formula: C18H29NO2; molecular weight 291.44 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Hypertensive disorder

Off-label uses (1)

  • Angina pectoris

Contraindications (17)

  • Anaphylaxis
  • Bronchospasm
  • Cardiogenic shock
  • Complete atrioventricular block
  • Decompensated cardiac failure
  • Depressive disorder
  • Diabetes mellitus
  • Disease of liver
  • Kidney disease
  • Myasthenia gravis
  • Partial atrioventricular block
  • Pregnancy, function
  • Pulmonary emphysema
  • Raynaud's phenomenon
  • Right ventricular failure
  • Severe chronic obstructive pulmonary disease
  • Sinus bradycardia

Mechanism & targets

Mechanism of action (MoA)Adrenergic beta-Antagonists
Established pharmacologic classbeta-Adrenergic Blocker

Molecular targets (5)

TargetGeneActionActivity
Beta-2 adrenergic receptorADRB2antagonistKi 9.00
Beta-1 adrenergic receptorADRB1antagonistKi 8.80
5-hydroxytryptamine receptor 1AHtr1aunknownKi 8.62
5-hydroxytryptamine receptor 1AHTR1AunknownKi 7.92
Alpha-1-acid glycoprotein 1ORM1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1987-12-30FDA——

ATC classification

ATC codeTherapeutic hierarchy
C07AA23CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS › Beta blocking agents, non-selective
C07CA23CARDIOVASCULAR SYSTEM › BETA BLOCKING AGENTS › BETA BLOCKING AGENTS AND OTHER DIURETICS › Beta blocking agents, non-selective, and other diuretics

Chemical structure

Molecular formulaC18H29NO2
Molecular weight291.44 g/mol
CAS number38363-40-5
InChIKeyKQXKVJAGOJTNJS-HNNXBMFYSA-N
PubChem CID37464
CC(C)(C)NC[C@H](O)COC1=C(C=CC=C1)C1CCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Penbutolol used for?

DrugCentral lists the following indications for Penbutolol: Hypertensive disorder.

How does Penbutolol work?

Penbutolol is classified as Adrenergic beta-Antagonists; its molecular targets in DrugCentral include ADRB2 (antagonist), ADRB1 (antagonist), Htr1a and HTR1A.

When was Penbutolol first approved?

Penbutolol was first approved by the FDA in 1987.

What drug class does Penbutolol belong to?

Penbutolol is in the beta-Adrenergic Blocker class.

What is the chemical formula of Penbutolol?

Penbutolol has the molecular formula C18H29NO2 and a molecular weight of 291.44 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1987-12-30
AgencyFDA
Targets5
Indications1
FormulaC18H29NO2
DrugCentral ID2078
Interactive profile